Genmab (NDQ:GMAB) enters FY26 as one of the most profitable royalty engines in global oncology. The company’s antibody ...

United Therapeutics (NDQ:UNTR) is the only listed company attempting to industrialise the supply of transplantable organs.

Verizon (VZ) reports Q3 earnings Monday as SpaceX eyes 80,000 US cell sites. See Wall Street forecasts and what could move ...

Zip Co (ASX:ZIP) reconfirmed FY27 cash EBTDA guidance of A$340m after a US$7.2m US fraud event and 34% US TTV growth in 1Q27.

Elixir Energy (ASX:EXR) has farmed out half its Taroom Trough acreage to Beach Energy in a A$205 million deal that reprices ...

Temple & Webster (ASX:TPW) guided FY27 EBITDA to A$33-40m at its AGM, up 50-80%, as margin discipline and private label ...

Fortescue (ASX:FMG) shipped 46.8Mt in Q1 FY27 but sold only 42.9Mt as the CMRG pricing dispute leaves inventory piling up.

Hawk Resources (ASX:HWK) lab assays at Olympus returned 11ppm scandium against historical pXRF readings of 742ppm, raising ...

Orbital Corporation (ASX:OEC) signs first A$3.7m Power by the Hour contract with American Aerospace, shifting its UAV engine ...

Why is the US stock market falling today? Nvidia, Tesla and Meta face pressure as AI spending fears, weak tech sentiment and rising oil prices hit Wall Street.

Tempus AI (NDQ:TEM) is another one of those early-stage NASDAQ biotechs hoping to go from the tens of billions into the hundreds of billions in market ...

BHP (ASX:BHP) copper production fell 19% in Q1 FY27, but bulk commodities, record WAIO output and the Jansen build steady the ...